Prime Medicine (PRME) Reiterated at Market Outperform by Citizens on AATD, WD Interest
Tweet Send to a Friend
Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $6.00 price target on Prime Medicine (NASDAQ: PRME).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
